Stakes Are High for Regeneron's Eylea HD as Genentech's
Navigating the landscape of Wet AMD Therapies During AMD Awareness Month...
Source: globenewswire.com
📰 Time Dynamix News
Time Dynamix News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Time Dynamix. Real-time updates on events, politics, business and more.
Changes Afoot for the Treatment of Psoriatic Arthritis with Marked Gains in Preference and ...
EXTON, PA, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Since the first US FDA-approved tumor necrosis factor (TNF) inhibitor in 2002 for the treatment of psoriatic arthritis (PsA), TNF’s have upheld
Maxine Yarnall Eli Lilly Taltz Novartis Cosentyx Spherix Network Eli Lilly Spherix Global Insight Realtime Dynamix
Source: eagletribune.com
US Gastroenterologist Projections Suggest Significant Shift in Ulcerative Colitis Landscape ...
Exton, Pennsylvania, Nov. 13, 2023 (GLOBE NEWSWIRE) -- In the past two months, the landscape of available treatments for ulcerative colitis (UC) has undergone a significant expansion, marked by the
Source: eagletribune.com
With Little Remaining Unmet Need for Injectable Biologics
Despite the increased efficacy of BMS’ Sotyktu over Amgen’s Otezla, dermatologists continue to express a desire for additional oral agents that bring...
Source: globenewswire.com
Another Medicine to Stop Migraine in its Tracks – Zavzpret™
Will Pfizer’s marketing power help Zavzpret™ rapidly gain share in the crowded migraine market?...
United States Abbvie Ubrelvy Eli Lilly Reyvow Spherix Network Spherix Global Insights Launch Dynamix
Source: globenewswire.com
First-to-Market Edge for Apellis's Syfovre in Geographic
Prospects for Syfovre uptake and trust in Apellis take a plunge following reports of intraocular inflammation, according to Spherix Global Insights...
United States Caroline Baumal Apelli Syfovre Novarti Beovu Iveric Bio American Society Of Retina Specialists
Source: globenewswire.com
At Eighteen Months Post-Launch, Impel's Trudhesa Has Struggled to Keep Up with Pfizer's Nurtec ODT and AbbVie's Ubrelvy, According to Spherix Global Insights
/PRNewswire/ -- Spherix Global Insights recently released data from their Launch Dynamix™: Trudhesa in Acute Treatment of Migraine (US) deep dive study...
Source: prnewswire.com
Genentech's Vabysmo Well-Received Amongst Ophthalmologists, but Use Continues to Lag the Competition, According to Spherix Global Insights
/PRNewswire/ -- According to Spherix Global Insights Launch Dynamix™: Vabysmo service, to no surprise, Regenerons Eylea continues to lead the charge in both...
Regeneron Eylea Chrystal Ferguson Scott Upham Spherix Network Corporate Communications Spherix Global Insight Launch Dynamix
Source: prnewswire.com
Familiarity with GSK's Jesduvroq® (daprodustat) Likely to Be Strong Driver of Adoption in Dialysis, According to Spherix Global Insights
/PRNewswire/ -- In the 32nd wave of ongoing tracking of the U.S. Renal Anemia market, Spherix surveyed 207 US nephrologists about overall patient management...
Scott Upham Corporate Communications Us Food Drug Administration Renal Physician Association Spherix Network Spherix Global Insights
Source: prnewswire.com
US Neurologists Cautiously Optimistic About Potential Approval of Pfizer's Zavegepant for the Acute Treatment of Migraine, According to Spherix Global Insights
/PRNewswire/ -- On February 16, The Lancet Neurology published the Phase 3 results of Pfizers zavegepant for the acute treatment of migraine. The CGRP...
Source: prnewswire.com